메뉴 건너뛰기




Volumn 351, Issue 9108, 1998, Pages 1043-1051

Migraine

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ERGOT ALKALOID; FLUNARIZINE; METHYSERGIDE; NADOLOL; NONSTEROID ANTIINFLAMMATORY AGENT; PIZOTIFEN; RIBOFLAVIN; SEROTONIN; SEROTONIN DERIVATIVE; SUMATRIPTAN; TIMOLOL; VALPROIC ACID; VERAPAMIL;

EID: 0032481904     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)11370-8     Document Type: Review
Times cited : (483)

References (70)
  • 1
    • 0002313754 scopus 로고    scopus 로고
    • Epidemiology and comorbidity of migraine
    • In: Goadsby PJ, Silbertein SD, eds. Boston: Butterworth-Heinemann
    • Lipton RB, Stewart WF. Epidemiology and comorbidity of migraine. In: Goadsby PJ, Silbertein SD, eds. Headache. Boston: Butterworth-Heinemann, 1997: 75-97.
    • (1997) Headache , pp. 75-97
    • Lipton, R.B.1    Stewart, W.F.2
  • 2
    • 0346031709 scopus 로고    scopus 로고
    • Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
    • Headache Classifiction Committee of the International Headache Society
    • Headache Classifiction Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1998; 8 (suppl 7): 1-96.
    • (1998) Cephalalgia , vol.8 , Issue.SUPPL. 7 , pp. 1-96
  • 4
    • 0030927625 scopus 로고    scopus 로고
    • A 40-year follow-up of school children with migraine
    • Bille B A 40-year follow-up of school children with migraine. Cephalalgia. 17:1997;488-491.
    • (1997) Cephalalgia , vol.17 , pp. 488-491
    • Bille, B.1
  • 5
    • 0029988603 scopus 로고    scopus 로고
    • A nosographic analysis of the migraine aura in a general population
    • Russell MB, Olesen J A nosographic analysis of the migraine aura in a general population. Brain. 119:1996;355-361.
    • (1996) Brain , vol.119 , pp. 355-361
    • Russell, M.B.1    Olesen, J.2
  • 6
    • 0028787008 scopus 로고
    • Mitochondria, magnesium and migraine
    • Welch KMA, Ramadan NM Mitochondria, magnesium and migraine. J Neurol Sci. 134:1995;9-14.
    • (1995) J Neurol Sci , vol.134 , pp. 9-14
    • Welch, K.M.A.1    Ramadan, N.M.2
  • 7
    • 0029089247 scopus 로고
    • Clinical spectrum of CADASIL: A study of 7 families
    • Chabriat H, Vahedi Ket al. Clinical spectrum of CADASIL: a study of 7 families. Lancet. 346:1995;934-939.
    • (1995) Lancet , vol.346 , pp. 934-939
    • Chabriat, H.1    Vahedi, K.2
  • 8
    • 0029651792 scopus 로고
    • Analgesic headache
    • Olesen J Analgesic headache. BMJ. 310:1995;479-480.
    • (1995) BMJ , vol.310 , pp. 479-480
    • Olesen, J.1
  • 9
    • 0025811621 scopus 로고
    • Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs
    • Hering R, Steiner TJ Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet. 337:1991;1442-1443.
    • (1991) Lancet , vol.337 , pp. 1442-1443
    • Hering, R.1    Steiner, T.J.2
  • 10
    • 0029086431 scopus 로고
    • The utility of the encephalogram in the evaluation of patients presenting with headache
    • Gronseth GS, Greenberg MK The utility of the encephalogram in the evaluation of patients presenting with headache. Neurology. 45:1995;1263-1267.
    • (1995) Neurology , vol.45 , pp. 1263-1267
    • Gronseth, G.S.1    Greenberg, M.K.2
  • 11
    • 0028453699 scopus 로고
    • Migraine prevalence: A review of population-based studies
    • Stewart WF, Schechter A, Rasmussen BK. Migraine prevalence: a review of population-based studies. Neurology 1994; 44 (suppl 4): S17-23.
    • (1994) Neurology , vol.44 , Issue.SUPPL. 4
    • Stewart, W.F.1    Schechter, A.2    Rasmussen, B.K.3
  • 12
    • 0028100273 scopus 로고
    • Prevalence of headache and migraine in schoolchildren
    • Abu-Arefeh I, Russell G Prevalence of headache and migraine in schoolchildren. BMJ. 309:1994;765-769.
    • (1994) BMJ , vol.309 , pp. 765-769
    • Abu-Arefeh, I.1    Russell, G.2
  • 13
    • 0028452080 scopus 로고
    • Migraine heterogeneity: Disability, pain intensity, and attack frequency and duration
    • Stewart WF, Schechter A, Lipton RB Migraine heterogeneity: disability, pain intensity, and attack frequency and duration. Neurology. 44(suppl 4):1994;S24-39.
    • (1994) Neurology , vol.44 , Issue.SUPPL. 4 , pp. 24-39
    • Stewart, W.F.1    Schechter, A.2    Lipton, R.B.3
  • 14
    • 0025355959 scopus 로고
    • Migraine-related stroke in the context of the International Headache Society Classification of head pain
    • Welch KMA, Levine SR Migraine-related stroke in the context of the International Headache Society Classification of head pain. Arch Neurol. 47:1990;458-462.
    • (1990) Arch Neurol , vol.47 , pp. 458-462
    • Welch, K.M.A.1    Levine, S.R.2
  • 16
    • 0031035487 scopus 로고    scopus 로고
    • Clinical neurophysiology of headache
    • In: Mathew NT, ed. Philadelphia: Saunders Company
    • Schoenen J. Clinical neurophysiology of headache. In: Mathew NT, ed. Neurologic clinics (advances in headache). Philadelphia: Saunders Company, 1997: 85-107.
    • (1997) Neurologic Clinics (Advances in Headache) , pp. 85-107
    • Schoenen, J.1
  • 17
    • 0030201086 scopus 로고    scopus 로고
    • Interictal cortical hyperexcitability in migraine patients demonstrated with transcranial magnetic stimulation
    • Van Der Kamp W, Maassen Van Den Brink A, Ferrari MD, Van Dijk JG Interictal cortical hyperexcitability in migraine patients demonstrated with transcranial magnetic stimulation. J Neurol Sci. 139:1996;106-110.
    • (1996) J Neurol Sci , vol.139 , pp. 106-110
    • Van Der Kamp, W.1    Maassen Van Den Brink, A.2    Ferrari, M.D.3    Van Dijk, J.G.4
  • 19
    • 0029012866 scopus 로고
    • Brain stem activation in spontaneous human migraine attacks
    • Weiller C, May A, Limmroth Vet al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1:1995;658-660.
    • (1995) Nat Med , vol.1 , pp. 658-660
    • Weiller, C.1    May, A.2    Limmroth, V.3
  • 20
    • 0028960823 scopus 로고
    • The nitric oxide hypothesis of migraine and other vascular headaches
    • Olesen J, Thomsen LL, Lassen LH, Olesen IJ The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia. 15:1995;94-100.
    • (1995) Cephalalgia , vol.15 , pp. 94-100
    • Olesen, J.1    Thomsen, L.L.2    Lassen, L.H.3    Olesen, I.J.4
  • 22
    • 0028325495 scopus 로고
    • Pathophysiology of the migraine aura: The spreading depression theory
    • Lauritzen M Pathophysiology of the migraine aura: the spreading depression theory. Brain. 117:1994;199-210.
    • (1994) Brain , vol.117 , pp. 199-210
    • Lauritzen, M.1
  • 23
    • 0020630304 scopus 로고
    • Changes in regional cerebral blood flow during the course of classic migraine attacks
    • Lauritzen M, Skyhøj Olsen T, Lassen NA, Paulson OB Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol. 13:1983;633-641.
    • (1983) Ann Neurol , vol.13 , pp. 633-641
    • Lauritzen, M.1    Skyhøj Olsen, T.2    Lassen, N.A.3    Paulson, O.B.4
  • 24
    • 0026683693 scopus 로고
    • Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine
    • Moskowitz MA Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci. 13:1992;307-312.
    • (1992) Trends Pharmacol Sci , vol.13 , pp. 307-312
    • Moskowitz, M.A.1
  • 25
    • 0002635215 scopus 로고    scopus 로고
    • Pathophysiology of migraine: A disease of the brain
    • In: Goadsby PJ, Silbertstein SD, eds. Boston: Butterworth-Heinemann
    • Goadsby PJ. Pathophysiology of migraine: a disease of the brain. In: Goadsby PJ, Silbertstein SD, eds. Headache. Boston: Butterworth-Heinemann, 1997: 5-25.
    • (1997) Headache , pp. 5-25
    • Goadsby, P.J.1
  • 27
    • 0027258572 scopus 로고
    • On serotonin and migraine: A clinical and pharmacological review
    • Ferrari MD, Saxena PF On serotonin and migraine: a clinical and pharmacological review. Cephalalgia. 13:1993;151-156.
    • (1993) Cephalalgia , vol.13 , pp. 151-156
    • Ferrari, M.D.1    Saxena, P.F.2
  • 29
    • 0029049743 scopus 로고
    • Practice parameter: Appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus
    • Report of the Quality Standards Subcommittee of the American Academy of Neurology
    • Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Neurology 1995; 45: 585-87.
    • (1995) Neurology , vol.45 , pp. 585-587
  • 30
    • 0001286363 scopus 로고    scopus 로고
    • Serotonin receptor involvement in the pathogenesis and treatment of migraine
    • In: Goadsby PJ, Silberstein SD, eds. Boston, Butterworth-Heinemann
    • Martin GR. Serotonin receptor involvement in the pathogenesis and treatment of migraine. In: Goadsby PJ, Silberstein SD, eds. Headache. Boston, Butterworth-Heinemann, 1997: 25-39.
    • (1997) Headache , pp. 25-39
    • Martin, G.R.1
  • 31
    • 0030272955 scopus 로고    scopus 로고
    • 1B/D receptor agonist zolmitriptan (311C90): Are brain stem sites therapeutic target in migraine?
    • 1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine? Pain. 67:1996;355-359.
    • (1996) Pain , vol.67 , pp. 355-359
    • Goadsby, P.J.1    Hoskin, K.L.2
  • 32
    • 0030914002 scopus 로고    scopus 로고
    • Rizatriptan has central antinociceptive effects against durally evoked reponses
    • Cumberbatch MJ, Hill RG, Hargreaves RJ Rizatriptan has central antinociceptive effects against durally evoked reponses. Eur J Pharmacol. 328:1997;37-40.
    • (1997) Eur J Pharmacol , vol.328 , pp. 37-40
    • Cumberbatch, M.J.1    Hill, R.G.2    Hargreaves, R.J.3
  • 33
    • 0027175057 scopus 로고
    • Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption
    • Kaube H, Hoskin KL, Goadsby PJ Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption. Br J Pharmacol. 109:1993;788-792.
    • (1993) Br J Pharmacol , vol.109 , pp. 788-792
    • Kaube, H.1    Hoskin, K.L.2    Goadsby, P.J.3
  • 34
    • 0027419370 scopus 로고
    • Clinical and experimental effects of sumatriptan in humans
    • Ferrari MD, Saxena PR Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol Sci. 14:1993;129-134.
    • (1993) Trends Pharmacol Sci , vol.14 , pp. 129-134
    • Ferrari, M.D.1    Saxena, P.R.2
  • 35
    • 0031283073 scopus 로고    scopus 로고
    • 1B-immunoreactivity within the human trigemino-cerebrovascular system: Implications for the discovery of new antimigraine drugs
    • 1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalgia. 17:1997;833-842.
    • (1997) Cephalgia , vol.17 , pp. 833-842
    • Longmore, J.1    Shaw, D.2    Hopkins, R.3
  • 36
    • 0026056238 scopus 로고
    • Mode of action of the anti-migraine drug sumatriptan
    • Humphrey PPA, Feniuk W Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol Sci. 12:1991;444-446.
    • (1991) Trends Pharmacol Sci , vol.12 , pp. 444-446
    • Humphrey, P.P.A.1    Feniuk, W.2
  • 37
    • 0000682979 scopus 로고    scopus 로고
    • CP-122 288 blocks neurogenic inflammation, but is not effective in aborting migraine attacks: Results of two controlled trials
    • Roon K, Diener HC, Ellis Pet al. CP-122 288 blocks neurogenic inflammation, but is not effective in aborting migraine attacks: results of two controlled trials. Cephalalgia. 17:1997;245.
    • (1997) Cephalalgia , vol.17 , pp. 245
    • Roon, K.1    Diener, H.C.2    Ellis, P.3
  • 38
    • 85030338420 scopus 로고    scopus 로고
    • Migraine, ataxia, and epilepsy: A challenging spectrum of genetic determined calcium channelopathies
    • for the Dutch Migraine Genetics Research Group. in press
    • Terwindt GM, Ophoff RA, Haan J, Frants RR, Ferrari MD for the Dutch Migraine Genetics Research Group. Migraine, ataxia, and epilepsy: a challenging spectrum of genetic determined calcium channelopathies. Eur J Human Genet (in press).
    • Eur J Human Genet
    • Terwindt, G.M.1    Ophoff, R.A.2    Haan, J.3    Frants, R.R.4    Ferrari, M.D.5
  • 39
    • 0029119352 scopus 로고
    • Increased familial risk and evidence of genetic factor in migraine
    • Russell MB, Olesen J Increased familial risk and evidence of genetic factor in migraine. BMJ. 311:1995;541-544.
    • (1995) BMJ , vol.311 , pp. 541-544
    • Russell, M.B.1    Olesen, J.2
  • 40
    • 0030657961 scopus 로고    scopus 로고
    • A new locus for hemiplegic migraine maps to chromosome 1q31
    • Gardner K, Barmada MM, Ptacek LJ, Hoffman EP A new locus for hemiplegic migraine maps to chromosome 1q31. Neurology. 49:1997;1231-1238.
    • (1997) Neurology , vol.49 , pp. 1231-1238
    • Gardner, K.1    Barmada, M.M.2    Ptacek, L.J.3    Hoffman, E.P.4
  • 41
    • 0027306090 scopus 로고
    • A gene for familial hemiplegic migraine maps to chronosome 19
    • Joutel A, Bousser MG, Biousse Vet al. A gene for familial hemiplegic migraine maps to chronosome 19. Nat Genet. 5:1993;40-45.
    • (1993) Nat Genet , vol.5 , pp. 40-45
    • Joutel, A.1    Bousser, M.G.2    Biousse, V.3
  • 42
    • 0031470730 scopus 로고    scopus 로고
    • Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity
    • Ducros A, Joutel A, Vahedi Ket al. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol. 42:1997;885-890.
    • (1997) Ann Neurol , vol.42 , pp. 885-890
    • Ducros, A.1    Joutel, A.2    Vahedi, K.3
  • 44
    • 0027361402 scopus 로고
    • Drug therapy of migraine
    • Welch KMA Drug therapy of migraine. N Engl J Med. 329:1993;1476-1484.
    • (1993) N Engl J Med , vol.329 , pp. 1476-1484
    • Welch, K.M.A.1
  • 45
    • 0001980483 scopus 로고    scopus 로고
    • Drug treatment of migraine attacks
    • In: Goadsby PJ, Silberstein SD, eds. Boston: Butterworth-Heinemann
    • Ferrari MD, Haan J. Drug treatment of migraine attacks. In: Goadsby PJ, Silberstein SD, eds. Headache. Boston: Butterworth-Heinemann, 1997: 117-31.
    • (1997) Headache , pp. 117-131
    • Ferrari, M.D.1    Haan, J.2
  • 46
    • 0031025883 scopus 로고    scopus 로고
    • Prophylactic pharmacotherapy of migraine; some practical guidelines
    • In: Mathew NT, ed. Philadelphia: Saunders
    • Tfelt-Hansen P. Prophylactic pharmacotherapy of migraine; some practical guidelines. In: Mathew NT, ed. Neurologic clinics (advances in headache). Philadelphia: Saunders, 1997; 153-67.
    • (1997) Neurologic Clinics (Advances in Headache) , pp. 153-167
    • Tfelt-Hansen, P.1
  • 47
    • 0001466260 scopus 로고    scopus 로고
    • High-dose riboflavin as a novel prophylactic antimigraine therapy: Results from a double blind, randomized, placebo-controlled trial
    • Schoenen J, Jacquy J, Lenaerts M High-dose riboflavin as a novel prophylactic antimigraine therapy: results from a double blind, randomized, placebo-controlled trial. Cephalalgia. 17:1997;244.
    • (1997) Cephalalgia , vol.17 , pp. 244
    • Schoenen, J.1    Jacquy, J.2    Lenaerts, M.3
  • 48
    • 0030908941 scopus 로고    scopus 로고
    • Migraine prophylactic drugs: Proof of efficacy, utilization and cost
    • Ramadan NM, Schultz LL, Gilkey SJ Migraine prophylactic drugs: proof of efficacy, utilization and cost. Cephalalgia. 17:1997;73-80.
    • (1997) Cephalalgia , vol.17 , pp. 73-80
    • Ramadan, N.M.1    Schultz, L.L.2    Gilkey, S.J.3
  • 50
    • 85030338682 scopus 로고    scopus 로고
    • Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: A systematic review based on number needed to treat
    • in press
    • Tfelt-Hansen P. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat. Cephalalgia (in press).
    • Cephalalgia
    • Tfelt-Hansen, P.1
  • 51
    • 0028868649 scopus 로고
    • Migraine and cluster headache: Their management with sumatriptan: A critical review of the current clinical experience
    • Wilkinson M, Pfaffenrath V, Schoenen J, Deiner HC, Steiner TJ Migraine and cluster headache: their management with sumatriptan: a critical review of the current clinical experience. Cephalalgia. 15:1995;337-357.
    • (1995) Cephalalgia , vol.15 , pp. 337-357
    • Wilkinson, M.1    Pfaffenrath, V.2    Schoenen, J.3    Deiner, H.C.4    Steiner, T.J.5
  • 52
    • 0029127294 scopus 로고
    • The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migrain
    • Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migrain. Lancet. 346:1995;923-926.
    • (1995) Lancet , vol.346 , pp. 923-926
    • Tfelt-Hansen, P.1    Henry, P.2    Mulder, L.J.3    Scheldewaert, R.G.4    Schoenen, J.5    Chazot, G.6
  • 53
    • 0030055536 scopus 로고    scopus 로고
    • Sumatriptan in clinical practice: A two year review of 453 migraine patients
    • Visser WH, de Vriend RHM, Jaspers NMWH, Ferrari MD Sumatriptan in clinical practice: a two year review of 453 migraine patients. Neurology. 47:1996;46-51.
    • (1996) Neurology , vol.47 , pp. 46-51
    • Visser, W.H.1    De Vriend, R.H.M.2    Jaspers, N.M.W.H.3    Ferrari, M.D.4
  • 55
    • 0030473835 scopus 로고    scopus 로고
    • Chest symptoms after sumatriptan: A two-year clinical practice review in 735 consecutive migraine patients
    • Visser WH, Jaspers NMWH, de Vriend RHM, Ferrari MD Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients. Cephalalgia. 16:1996;554-559.
    • (1996) Cephalalgia , vol.16 , pp. 554-559
    • Visser, W.H.1    Jaspers, N.M.W.H.2    De Vriend, R.H.M.3    Ferrari, M.D.4
  • 56
    • 0025765727 scopus 로고
    • Migraine pain associated with middle cerebral artery dilation: Reversal by sumatriptan
    • Friberg L, Olesen J, Iversen HK, Sperling B Migraine pain associated with middle cerebral artery dilation: reversal by sumatriptan. Lancet. 338:1991;13-17.
    • (1991) Lancet , vol.338 , pp. 13-17
    • Friberg, L.1    Olesen, J.2    Iversen, H.K.3    Sperling, B.4
  • 58
    • 85088331016 scopus 로고    scopus 로고
    • A multinational investigation of the impact of subcutaneous sumatriptan
    • Heywood J, Bouchard J, Cortelli Pet al. A multinational investigation of the impact of subcutaneous sumatriptan. Pharmacoeconomics. 11(1):1997;11-50.
    • (1997) Pharmacoeconomics , vol.11 , Issue.1 , pp. 11-50
    • Heywood, J.1    Bouchard, J.2    Cortelli, P.3
  • 61
    • 0029824318 scopus 로고    scopus 로고
    • Rizatriptan vs sumatriptan in the acute treatment of migraine
    • for the Dutch/US Rizatriptan Study Group
    • Visser WH, Terwindt GM, Reines SA, Jiang K, Lines CR, Ferrari MD, for the Dutch/US Rizatriptan Study Group. Rizatriptan vs sumatriptan in the acute treatment of migraine. Arch Neurol 1996; 53: 1132-37.
    • (1996) Arch Neurol , vol.53 , pp. 1132-1137
    • Visser, W.H.1    Terwindt, G.M.2    Reines, S.A.3    Jiang, K.4    Lines, C.R.5    Ferrari, M.D.6
  • 62
    • 0002928496 scopus 로고    scopus 로고
    • Evidence for the improved efficacy and safety of electriptan compared with sumatriptan
    • Diener HC Evidence for the improved efficacy and safety of electriptan compared with sumatriptan. Cephalalgia. 17:1997;477.
    • (1997) Cephalalgia , vol.17 , pp. 477
    • Diener, H.C.1
  • 63
    • 0030769110 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment or migraine
    • Gijsman H, Kramer MS, Sargent Jet al. Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment or migraine. Cephalalgia. 17:1997;647-651.
    • (1997) Cephalalgia , vol.17 , pp. 647-651
    • Gijsman, H.1    Kramer, M.S.2    Sargent, J.3
  • 64
    • 0030695880 scopus 로고    scopus 로고
    • Clinical efficacy and tolerability of 2·5 mg zolmiriptan for the acute treatment of migraine
    • on behalf of the 042 Clinical Trial Study Group
    • Solomon GD, Cady RK, Klapper JA, et al. on behalf of the 042 Clinical Trial Study Group. Clinical efficacy and tolerability of 2·5 mg zolmiriptan for the acute treatment of migraine NEurology 1997; 49: 1219-25.
    • (1997) NEurology , vol.49 , pp. 1219-1225
    • Solomon, G.D.1    Cady, R.K.2    Klapper, J.A.3
  • 65
    • 0030657702 scopus 로고    scopus 로고
    • Optimizing; the dose of zolmitriptan (Zomig,*311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study
    • on behalf of the 017 Clinical Trial Study Group
    • Rapoport AM, Ramadan NM, Adelman JU, et al. on behalf of the 017 Clinical Trial Study Group. Optimizing; the dose of zolmitriptan (Zomig,*311C90) for the acute treatment of migraine. a multicenter, double-blind, placebo-controlled, dose range-finding study. Neurology 1997; 49: 1210-18.
    • (1997) Neurology , vol.49 , pp. 1210-1218
    • Rapoport, A.M.1    Ramadan, N.M.2    Adelman, J.U.3
  • 66
    • 0031454716 scopus 로고    scopus 로고
    • Naratriptan is effective and well tolerated in the acute treatment of migraine: Results of a double-blind, placebo-controlled, crossover study
    • on behalf of the Naratriptan S2WA3003 Study Group
    • Mathew NT, Asgharnejad M, Peykamian M, Laurenza A, on behalf of the Naratriptan S2WA3003 Study Group. Naratriptan is effective and well tolerated in the acute treatment of migraine: results of a double-blind, placebo-controlled, crossover study. Neurology 1997; 49: 1485-90.
    • (1997) Neurology , vol.49 , pp. 1485-1490
    • Mathew, N.T.1    Asgharnejad, M.2    Peykamian, M.3    Laurenza, A.4
  • 67
    • 0028855297 scopus 로고
    • Dihydroergotamine nasal spray
    • Gijsman HJ, Ferrari MD Dihydroergotamine nasal spray. Neurology. 45:1995;397-480.
    • (1995) Neurology , vol.45 , pp. 397-480
    • Gijsman, H.J.1    Ferrari, M.D.2
  • 68
    • 0030020852 scopus 로고    scopus 로고
    • A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine
    • Winner P, Ricalde O, Le Force B, Saper J, Margul B A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol. 53:1996;180-184.
    • (1996) Arch Neurol , vol.53 , pp. 180-184
    • Winner, P.1    Ricalde, O.2    Le Force, B.3    Saper, J.4    Margul, B.5
  • 69
    • 0030044447 scopus 로고    scopus 로고
    • Side effects of ergotamine
    • Meijler WJ Side effects of ergotamine. Cephalalgia. 16:1996;5-10.
    • (1996) Cephalalgia , vol.16 , pp. 5-10
    • Meijler, W.J.1
  • 70
    • 0026048813 scopus 로고
    • Myocardial ischemia related to ergot alkaloids: A case report and literature review
    • Galer BS, Lipton RB, Solomon S, Newman LC, Spierings ELH Myocardial ischemia related to ergot alkaloids: a case report and literature review. Headache. 31:1991;446-451.
    • (1991) Headache , vol.31 , pp. 446-451
    • Galer, B.S.1    Lipton, R.B.2    Solomon, S.3    Newman, L.C.4    Spierings, E.L.H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.